
Bruce Given appointed chairman of ICON
pharmafile | January 18, 2010 | Appointment | Research and Development | ICON, appointment, research and development
Irish contract research organisation ICON has appointed Bruce Given chairman.
He succeeds out-going chairman John Climax who co-founded the company in 1990 with former chairman Ronan Lambe, and will retire but remain on ICON’s board.
Given said: “We are extremely grateful for the extraordinary leadership and commitment that John has provided to ICON in his 20 years with the company, first as its co-founder and chief executive, and over the past seven years in his role as chairman.
“His vision and passionate commitment to ICON’s performance, people and clients have been the cornerstones of our success and we are delighted that he will remain on the board to help us forge a successful future for the company. It is an honour to succeed him.”
Given has been an ICON board member since 2004 and was most recently a healthcare products consultant.
From 2002 to 2007 he was president and chief executive of US firm Encysive Pharmaceuticals and prior to that spent nine years at Johnson & Johnson in a variety of roles.
He has also held various executive and senior management positions at Sandoz Pharma, Sandoz Research Institute and Schering-Plough Corporation. Prior to entering the pharmaceutical industry, he was on the medical faculty at the University of Chicago.
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …






